吡唑锌配合物的合成、晶体结构及抗肝癌细胞活性

通过溶剂挥发法合成了锌配合物[Zn（Hppo）₂（ppo） Cl]（1）,Hppo=5-苯基-3-羟基吡唑,利用元素分析、FTIR以及X射线衍射法对配合物1进行表征。晶体结构显示配合物属于单斜晶系,P2₁空间群。检测了配合物1对肝癌细胞HepG2、Hep3B和Huh7的细胞形态与细胞毒性的影响,结果表明配合物1对肿瘤细胞具有明显的抑制作用。     

4-(2-羟基-3-氯)苯基-2,2'':6'',2"-三联吡啶Cu(Ⅱ)配合物的合成、结构表征及抗肿瘤活性

以4-(2-羟基-3-氯)苯基-2,2′∶6′,2″-三联吡啶(HL)为配体,合成了一种新的铜(Ⅱ)配合物[Cu2(μ-L-κO,O)2Cl2](1),并通过红外光谱、电喷雾质谱、元素分析及单晶X射线衍射分析等方法对配合物1进行结构表征。配合物1为双核结构,中心铜(Ⅱ)离子为五配位扭曲四方锥几何构型,每个铜离子与1个Cl-以及来自配体(L-)的2个N原子和2个羟基O原子配位,2个铜(Ⅱ)离子通过羟基的桥联形成双核结构。MTT实验结果表明:配合物1对所选5种癌细胞株表现出不同的抑制活性,尤其是对MGC80-3细胞的抑制作用最明显,抑制率高达(84.30±1.28)%,其IC50值为(3.36±0.43)μmol·L-1。流式细胞术分析结果显示:配合物1能诱导MGC80-3细胞凋亡。在配合物1浓度为4.5μmol·L-1时,MGC80-3的凋亡百分数为41.4%。此外,配合物1将MGC80-3细胞阻滞于G1期,从而抑制肿瘤细胞的生长。     

三个单核钌配合物的合成、表征及抗肿瘤活性（英文）

对3种单核钌配合物[Ru(bpy)_2(paH)]PF_6(1),[Ru(dmb)_2(paH)]PF_6(2),[Ru(phen)_2(paH)]PF_6(3)(bpy=2,2'-联吡啶,dmb=4,4'-二甲基-2,2'-联吡啶,phen=菲咯啉,paH=2-吡啶甲酸)进行合成,并通过元素分析、红外、核磁和电喷雾质谱对其进行表征。此外,对配合物进行了光谱学和电化学测试,电化学实验表明1~3在0.7-1.0 V范围内均有1个氧化还原峰,说明钌中心发生了氧化还原反应。最后通过MTT法(MTT为3-(4,5-二甲基噻唑-2)-2,5-二苯基四氮唑溴盐)对配合物进行了体外细胞毒性实验,结果表明:1~3对人乳腺癌细胞、胃癌细胞和肺癌细胞都表现出浓度依赖性,即随着配合物浓度的逐渐增大,细胞的存活率逐渐降低。值得注意的是2对乳腺癌细胞表现出非常明显的抑制作用(IC_(50)=2.85μmol·L~(-1))。     

多吡啶类双核镍配合物的合成、晶体结构及抗癌活性

合成了2个相似的多吡啶类双核镍配合物[Ni_2(L)_2Cl_2](ClO_4)_2·3H_2O (1)和[Ni_2(L)_2Cl_2](PF_6)_2 (2)(L=N,N-bis(pyridin-2-ylmethyl)-4-(4-((pyridin-2-ylmethyl)amino)benzyl)aniline),通过X射线单晶衍射对其结构进行测定并解析,并利用元素分析、红外光谱对其进行表征。另外,通过噻唑蓝(MTT)比色法检验了 2个配合物对HeLa细胞、BGC-823细胞、NCI-H460细胞以及HepG-2细胞的体外毒性作用,结果表明2个配合物均对NCI-H460细胞表现出良好的毒性作用,IC_(50)值分别为(26.0±2.2)μmol·L~(-1)(1)和(31.3±2.7) μmol·L-~1 (2)。进一步通过Hoechst 33342染色、活性氧水平检测、线粒体膜电位的测定和分析探究了配合物1的抗肿瘤作用机制,结果表明,该配合物可能通过线粒体途径来诱导细胞凋亡从而对癌细胞产生致死作用。     

有机锡1,1′-亚甲基双(1H-吡唑-4-甲酸酯)的合成、结构与抗肿瘤活性

通过1,1′-亚甲基双(1H-吡唑-4-甲酸)(CH2(PzCO2H)2)与R3SnOH或(R3Sn)2O的反应,合成了4个有机锡1,1′-亚甲基双(1H-吡唑-4-甲酸酯)衍生物(CH2(PzCO2SnR3)2,R=Ph(1),环己基(2),Et(3),n-Bu(4))。通过红外和核磁对这些配合物进行了详细的结构表征。配合物1和3的X射线单晶衍射分析表明,这2个配合物中的吡唑氮原子均没有参与配位,但它们的羧酸根却表现出明显不同的配位方式。配合物1中羧酸根为单齿配体,且该配合物表现为简单双核结构;配合物3中羧酸根为双齿配体,其通过羧基的桥式双齿配位方式形成具有32元大环结构单元的二维配位高分子。初步的生物活性测试表明,这些有机锡衍生物对MCF-7和A549细胞具有很好的体外细胞毒性。     

基于酰腙类Schiff碱的锌和镉配合物的合成、晶体结构和性质

采用溶剂挥发法合成了配合物[M(HBrsth)2](M=Zn(1),Cd(2),H2Brsth=5-溴水杨醛缩噻吩-2-甲酰腙)和配合物[Cd(L)2](3,HL=2-乙酰基吡啶缩异烟酰腙),并经元素分析、红外光谱、紫外光谱和热重分析等对它们进行了表征。用X射线单晶衍射分析确定了配合物1和3的晶体结构,1属单斜晶系,C2/c空间群,呈现一维链状配位聚合结构;3属正交晶系,C2cb空间群。用MTT法测试了配合物对人肝肿瘤细胞HEPG2和人结肠癌细胞SW620的增殖抑制作用。还研究了配合物的发光性质。     

有机锡1,1′-亚甲基双(1H-吡唑-4-甲酸酯)的合成、结构与抗肿瘤活性（英文）

通过1,1′-亚甲基双(1H-吡唑-4-甲酸)(CH_2(PzCO_2H)_2)与R_3SnOH或(R_3Sn)_2O的反应,合成了4个有机锡1,1′-亚甲基双(1H-吡唑-4-甲酸酯)衍生物(CH_2(PzCO_2SnR_3)_2,R=Ph (1),环己基(2),Et (3),n-Bu (4))。通过红外和核磁对这些配合物进行了详细的结构表征。配合物1和3的X射线单晶衍射分析表明,这2个配合物中的吡唑氮原子均没有参与配位,但它们的羧酸根却表现出明显不同的配位方式。配合物1中羧酸根为单齿配体,且该配合物表现为简单双核结构;配合物3中羧酸根为双齿配体,其通过羧基的桥式双齿配位方式形成具有32元大环结构单元的二维配位高分子。初步的生物活性测试表明,这些有机锡衍生物对MCF-7和A549细胞具有很好的体外细胞毒性。     

靶向DNA的刚性配体的双核芳基钌配合物（英文）

以刚性配体1,3-bib(1,3-二(1H-咪唑-1-基)苯)与[Ru(η6-p-bip)Cl2]2(p-bip,联苯基团)为原料,合成了3种双核芳基钌配合物[Ru_2(η~6-p-bip)_2(1,3-bib)_2XY]X_2(X=Y=Cl-(1),X=Y=Br-(2),X=I-和Y=Cl-(3),并用核磁和质谱等对配合物进行了表征。配合物1的单晶衍射结果表明其具有一种刚性双核M2L2碗状结构,空腔中心有一个阴离子Cl-。配合物3对A549细胞有较高的抗癌活性(IC50=13.9μmol·L-1),与顺铂细胞毒性(IC50=15.2μmol·L-1)相当。紫外吸收光谱、圆二色谱、凝胶电泳法研究表明配合物1～3与DNA发生强烈的相互作用并且诱发DNA发生解旋。     

缩氨基硫脲Ni(Ⅱ)配合物的合成、晶体结构、DNA相互作用及抗肿瘤活性研究

合成了一种缩氨基硫脲Ni髤配合物[Ni(QCMT)2]Cl2·2CH3OH·1.5H2O(QCMT为喹啉-2-甲醛-N4-甲基缩氨基硫脲)。该配合物晶体属于三斜晶系,P1空间群,a=1.000 2(2)nm,b=1.093 9(2)nm,c=1.583 6(3)nm,α=93.99(3)°,β=105.25(3)°,γ=108.46(3)°。中心离子Ni2+处于变形八面体配位环境中。电子吸收光谱、荧光光谱及圆二色谱分析表明该配合物通过静电作用方式与DNA相结合。测定了该Ni髤配合物与配体(QCMT)对人乳腺癌细胞系MCF-7、人卵巢癌细胞系SKOV-3及人非小细胞肺癌耐顺铂细胞系A-549/CDDP的体外细胞毒活性。结果表明,Ni髤配合物对MCF-7细胞系的细胞毒活性强于顺铂,同时该配合物对MCF-7和SKOV-3两种细胞系的细胞毒活性明显优于其配体。     

3-(2-吡啶-3-乙烯基)-1H-吲哚钌配合物的合成及抗肿瘤性能

以3-(2-吡啶-3-乙烯基)-1H-吲哚(Indole)为配体与二联吡啶钌前体Ru(bpy)₂Cl₂进行配位反应,得到一种新型联吡啶钌配合物Ru-Indole,并通过1H NMR、ESI-MS及元素分析对配体及配合物进行了表征。研究结果表明,配合物具有良好的脂溶性,使得药物能够顺利地进入细胞内,克服了钌类配合物脂溶性差的特点。进一步使用MTT法、流式细胞术、共聚焦成像及蛋白免疫印迹法对Ru-Indole的抗肿瘤活性及诱导肿瘤细胞死亡的机制进行了深入的探究。结果发现,Ru-Indole与配体Indole及前体Ru(bpy)₂Cl₂相比表现出良好的抗肿瘤活性,表明引入的吲哚配体提高了配合物的脂溶性,提高了配合物的细胞摄取量,最终有效提高了配合物的细胞毒性。同时通过共聚焦显微镜及电感耦合等离子体质谱(ICP-MS)发现Ru-Indole富集在肿瘤细胞的线粒体和溶酶体中,通过线粒体通路诱导线粒体膜电位的改变,并通过细胞自噬的方式诱导细胞死亡。     

Syntheses,crystal structures,and urease inhibitory properties of copper(II) and zinc(II) complexes with 2-bromo-4-chloro-6-[(2-dimethylaminoethylimino)methyl]phenol

A new copper(II) complex, [CuL(μ _1,1-N₃)] _n (1), and a new zinc(II) complex, [ZnL(μ ₂-acetato-O, O′)₂] _n (2) (HL = 2-bromo-4-chloro-6-[(2-dimethylaminoethylimino)methyl]phenol), were prepared and characterized by elemental analyses, infrared spectroscopy, and single-crystal X-ray diffraction. Complex 1 is an end-on azide-bridged polynuclear copper(II) complex and 2 is a syn–anti bidentate acetate-bridged polynuclear zinc(II) complex. Each metal in the complex is five-coordinate with square-pyramidal geometry. Complex 1 shows good urease inhibitory properties, while 2 does not.     

Synthesis,characterization, and crystal structure of two zinc(II) complexes with a Schiff base derived from amantadine

By condensation of amantadine and 4-methoxysalicylaldehyde a new Schiff base HL was synthesized. A mixture of HL and zinc(II) chloride in an alcoholic medium leads to [Zn(HL)₂Cl₂] (1). However, the same reactants gave another different complex (ZnL₂) (2) in the presence of NaOH. The two complexes were characterized by IR, ¹H NMR, elemental analysis, molar conductance, and single-crystal X-ray diffraction. X-ray diffraction analysis reveals that complex 1 crystallizes in the triclinic system, Pī space group; each asymmetric unit consists of one zinc(II), two HL, and two chlorides. The tetra coordination of central zinc is attained by two chlorides and two oxygens from the Schiff base, forming a distorted tetrahedral geometry. Complex 2 crystallizes in the monoclinic system, P2₁/c space group; each asymmetric unit consists of one zinc(II) and two L. The tetra coordination of central zinc is attained by two nitrogens and two oxygens from the Schiff base, forming a distorted tetrahedral geometry.     

Synthesis,characterization, and crystal structures of cobalt(II), copper(II), and zinc(II) complexes of a bidentate iminophenol

A bidentate iminophenol (HL = 2-((4-methoxyphenylimino)methyl)-4,6-di-tert-butylphenol derived from condensation of 4-methoxyaniline and 3,5-di-tert-butyl-2-hydroxybenzaldehyde) was mixed with divalent metal salts to form the corresponding mononuclear metal complexes [M^II(L)₂] (M = Co (1), Cu (2), and Zn (3)). The complexes are characterized by different spectroscopic and analytical tools. X-ray crystal structures of the complexes revealed homoleptic mononuclear complexes with MN₂O₂ coordination. The cobalt(II) (1) and zinc(II) (3) complexes display a pseudo-tetrahedral coordination geometry, whereas the copper(II) complex (2) exhibits a distorted square-planar coordination. The zinc(II) complex (3) emits at 460 nm with a twofold enhancement of emission with respect to the free iminophenol.     

Influence of supporting ligand microenvironment on the aqueous stability and visible light-induced CO-release reactivity of zinc flavonolato species

The visible light-induced CO-release reactivity of the zinc flavonolato complex [(6-Ph₂TPA)Zn(3-Hfl)]ClO₄ (1) has been investigated in 1?:?1 H₂O?:?DMSO. Additionally, the effect of ligand secondary microenvironment on the aqueous stability and visible light-induced CO-release reactivity of zinc flavonolato species has been evaluated through the preparation, characterization, and examination of the photochemistry of compounds supported by chelate ligands with differing secondary appendages, [(TPA)Zn(3-Hfl)]ClO₄ (3; TPA = tris-2-(pyridylmethyl)amine) and [(bnpapa)Zn(3-Hfl)]ClO₄ (4; bnpapa = N,N-bis((6-neopentylamino-2-pyridyl)methyl)-N-((2-pyridyl)methyl)amine)). Compound 3 undergoes reaction in 1?:?1 H₂O?:?DMSO resulting in the release of the free neutral flavonol. Irradiation of acetonitrile solutions of 3 and 4 at 419 nm under aerobic conditions results in quantitative, photoinduced CO-release. However, the reaction quantum yields under these conditions are lower than that exhibited by 1, with 4 exhibiting an especially low quantum yield. Overall, the results of this study indicate that positioning a zinc flavonolato moiety within a hydrophobic microenvironment is an important design strategy toward further developing such compounds as CO-release agents for use in biological systems.     

Binding of zinc(II) macrocycles toward carboxylate ligands

Three new zinc(II) complexes, Zn(L1)(NO₃)₂ (1), {[Zn(L1)(fumarate)]·2H₂O} _n (2) and {[Zn(L2)(fumarate)]·DMF} _n (3) (L = 3,14-dimethyl-2,6,13,17-tetraazatricyclo [14,4,0^1.18,0^7.12]docosane) have been synthesized and characterized by analytical, spectroscopic, thermal and X-ray diffraction methods. The structure of the discrete neutral complex (1) shows that the central zinc(II) ion is coordinated axially by two nitrate ligands. In the structures (2) and (3), the carboxylate groups of the bridging fumarate ligands are coordinated to zinc(II) macrocycles, resulting in the formation of 1D coordination polymers. Apart from the fairly strong Zn–O bonds in (2) and (3), it is observed that the hydrogen bonds between the pre-organized N–H groups of the macrocycle and axial ligands appear to be important for the design and development of metal complexes having a strong Zn–O bond.     

偶氮桥连羧酸配体与Zn(Ⅱ)构建的二维配位聚合物的合成、晶体结构及荧光性质

合成了化合物3-(5-叔丁基-2-甲氧羰基甲氧基苯基)偶氮苯甲酸甲酯(Me2L),并以此为配体与醋酸锌在水热条件下通过自组装获得了1个二维的配位聚合物{[Zn(H2O)L]·H2O}n(1),通过红外、元素分析及X-射线单晶衍射等检测手段对所合成的化合物进行了结构表征,并测试了其荧光发射性质。相对于配位前驱体H2L的荧光发射,聚合物1的荧光发射略有红移。结构研究表明,该化合物中配体采取了常见的反式构型,形成了沿晶体学ab平面延伸的二维网状结构,聚合物中的溶剂水分子通过氢键连接在二维结构的内部。该配位聚合物的合成对于研究偶氮类配合物的光化学反应奠定了基础。     

N-(2-氧乙酸-3-甲氧基)苄叉二胺合锌(Ⅱ)配合物的合成、晶体结构及光学性质研究

本文通过修饰邻香草醛芳环上羟基的方法,得到两种Schiff碱配体:N,N′-二(2-氧乙酸-3-甲氧基)苄叉乙二胺(H2L1)和N,N′-二(2-氧乙酸-3-甲氧基)苄叉1,3-丙二胺(H2L2),利用水热合成方法以新合成的配体为基点设计合成了2个新的六配位Schiff碱锌(Ⅱ)配合物[Zn(L1)]·7H2O(1)和[Zn(L2)]·7H2O(2),通过元素分析、红外光谱和核磁共振光谱等测试手段对配合物进行了表征,并用X射线单晶衍射测得Zn(Ⅱ)配合物的晶体结构。X射线晶体学研究表明两种配合物晶体结构中都包含多个溶剂水分子,配合物1是以Zn(Ⅱ)为中心扭曲的三方棱柱构型,配合物2是以Zn(Ⅱ)为中心扭曲的八面体构型。初步研究了两种配合物的固体发光性,结果表明这两种配合物具有良好的光致发光的性能,有望在光学材料方面得到应用。     

N-(2-氧乙酸-3-甲氧基)苄叉二胺合锌(Ⅱ)配合物的合成、晶体结构及光学性质研究

本文通过修饰邻香草醛芳环上羟基的方法,得到两种Schiff碱配体:N,N'-二(2-氧乙酸-3-甲氧基)苄叉乙二胺(H₂L¹)和N,N′-二(2-氧乙酸-3-甲氧基)苄叉1,3-丙二胺(H₂L₂),利用水热合成方法以新合成的配体为基点设计合成了2个新的六配位Schiff碱锌(Ⅱ)配合物[Zn(L¹)]·7H₂O(1)和[Zn(L²)]·7H₂O(2),通过元素分析、红外光谱和核磁共振光谱等测试手段对配合物进行了表征,并用X射线单晶衍射测得Zn(Ⅱ)配合物的晶体结构。X射线晶体学研究表明两种配合物晶体结构中都包含多个溶剂水分子,配合物1是以Zn(Ⅱ)为中心扭曲的三方棱柱构型,配合物2构型是以Zn(Ⅱ)为中心扭曲的八面体构型。初步研究了两种配合物的固体发光性,结果表明这两种配合物具有良好的光致发光的性能,有望在光学材料方面得到应用。     

Syntheses and crystal structures of two complexes based on 2-amino-4,6-bis(4-pyridyl)-1,3,5-triazine

Two compounds based on 2-amino-4,6-bis(4-pyridyl)-1,3,5-triazine (4-HABPT), [Co(4-HABPT)₂(H₂O)₄](CH₃COO)₂ (1), and Zn(4-HABPT)₂Cl₂ (2) were obtained at room temperature. Single-crystal X-ray diffraction analyses indicate that 1 crystallizes in the triclinic P 1 with cobalt(II) coordinated by two 4-HABPT and four waters, two acetates are counter ions. The complex cations and acetates are linked to a 3-D framework by hydrogen bonds. Compound 2 crystallizes in the orthorhombic Pnc2 with zinc(II) coordinated by two 4-HABPT and two chlorides in a tetrahedral geometry; the complex also forms a 3-D framework by hydrogen bonds and π?···?π interactions.